-
A recently published study by an INBT research team from the labs of Hai-Quan Mao and Jonathan Schneck at the Johns Hopkins School of Medicine, shows that their design of new nano-sized artificial cells is effective at activating T cells, specialized immune cells, to destroy damaged and infected cells, as well as destroying cancer cells. Read More
-
Sure, you know how old you are, but what about your cells? Are they the same age? Are they older, younger? Why does it matter? Led by scientists at Johns Hopkins… Read More
-
By combining two treatment strategies, both aimed at boosting the immune system’s killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. And, they say, because the combination technique is easily tailored to different types of cancer, their findings — if confirmed in humans — have the potential to enhance treatment options for a wide variety of cancer patients. Read More
-
Blood vessels play a dual role in healing as well as spreading diseases in the body. While vascular systems carry vital nutrients, they are also a pathway for malignancies to infiltrate other body systems. The challenge for researchers is encouraging blood vessel formation in one instance, while inhibiting formation in another. Such was the theme of the 11th annual Johns Hopkins Nano-Bio Symposium, Engineering Vascularization, on Friday, May 5, 2017 at the Johns Hopkins School of Medicine. The symposium was jointly organized by Johns Hopkins Institute for NanoBioTechnology (INBT) and Physical Sciences-Oncology Center (PS-OC). Read More
